Large-scale testing (Phase 3)Study completedNCT01880697
What this trial is testing
Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvanted Influenza Study Vaccine in Adults Aged 18 Years and Above
Who this might be right for
Human Influenza
Novartis Vaccines 126